What Happened?
Cambridge, MA-based Sage-Therapeutics Appointed Aatiyah Paulding as Associate Director, People and Experience
Date of management change: September 15, 2020
Cambridge, MA-based Sage-Therapeutics Appointed Aatiyah Paulding as Associate Director, People and Experience
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage`s lead product candidate, ZULRESSO(TM) (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression.
Aatiyah Paulding is Associate Director, People and Experience at Sage Therapeutics. Previously, Aatiyah held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Coughlin Matt, Khan Akhlaq, Bentley Scott, Norrigan Paul, Vanno Lorelle, Larracey Andrew, Forte Dana, Turner Dustin, Sundberg Lori, Feener Tara, deBuzna Joe
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.